Evidence mapPaperPMID 41488618Full record

ReviewFrontiers in immunology2025

Viral reprogramming of glial metabolism as a driver of neuroinflammation.

Tamara Rodrigues, Gabriel Salles Beltrão, Heloísa Girardi, Aguinaldo R Pinto

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tamara RodriguesLaboratory of Applied Immunology, Department of Microbiology, Immunology and Parasitology, Center for Biological Sciences, Federal University of Santa Catarina, Florianópolis, Brazil.
Gabriel Salles Beltrão *Laboratory of Applied Immunology, Department of Microbiology, Immunology and Parasitology, Center for Biological Sciences, Federal University of Santa Catarina, Florianópolis, Brazil.
Heloísa Girardi *Laboratory of Applied Immunology, Department of Microbiology, Immunology and Parasitology, Center for Biological Sciences, Federal University of Santa Catarina, Florianópolis, Brazil.
Aguinaldo R PintoLaboratory of Applied Immunology, Department of Microbiology, Immunology and Parasitology, Center for Biological Sciences, Federal University of Santa Catarina, Florianópolis, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considerable attention has been recently devoted to the involvement of immune cells in the central nervous system (CNS) during infections with neurotropic viruses, such as SARS-CoV-2, HIV-1, and ZIKV. These viruses are capable of infecting astrocytes and microglia, the main glial cells in the CNS, responsible for regulating neuronal activity. Here, we discuss how viral infections lead to metabolic reprogramming toward aerobic glycolysis in these cells, enhancing pro-inflammatory pathways, such as inflammasome activation, resulting in the secretion of inflammatory cytokines that favor the development of neuroinflammation. In this mini review, we discuss the pivotal interplay between metabolism and immunity towards viral pathogenesis in the CNS, pointing out the relevance of therapeutic strategies targeting both metabolic and immunological pathways to enhance antiviral and neuroprotective responses.

Indexed as

COVID-19NeurogliaNeuroinflammatory DiseasesSARS-CoV-2AnimalsAstrocytesGlycolysisHIV-1HumansMicrogliaZika VirusCNSglial cellsinflammasomemetabolic reprogrammingneuroinflammationneurotropic viruses

Identifiers

PMID41488618
PMCPMC12757268

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.